Skip to content Skip to navigation

Bath salt research raises new concerns

December 21, 2011
by News release
| Reprints

New research by scientists at the National Institute on Drug Abuse indicates that, just like MDMA (Ecstasy), the active compounds in “bath salts—mephedrone and methylone—bind to monoamine transporters on the surface of some neurons.

This in turn leads to an increase in the brain chemicals serotonin, and, to a lesser extent dopamine, suggesting a mechanism that could underlie the addictive potential of these compounds. The study was published in Neuropsychopharmacology.

For a copy of the article by Baumann et al., go to: http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2011304a.html. To view a recent message from NIDA Director Dr. Nora Volkow on “Bath Salts,” go to: http://www.drugabuse.gov/about/welcome/MessageBathSalts211.html

For more information, please contact the NIDA Press Office at 301-443-6245 or media@nida.nih.gov.

Topics